Cerity Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16M Sell
205,160
-7,763
-4% -$607K 0.03% 406
2025
Q1
$15.4M Buy
212,923
+86,089
+68% +$6.24M 0.03% 386
2024
Q4
$9.21M Buy
126,834
+4,012
+3% +$291K 0.02% 502
2024
Q3
$8.1M Sell
122,822
-75,611
-38% -$4.99M 0.02% 554
2024
Q2
$18.3M Sell
198,433
-13,517
-6% -$1.25M 0.05% 293
2024
Q1
$20.3M Sell
211,950
-168,074
-44% -$16.1M 0.05% 292
2023
Q4
$29M Sell
380,024
-14,121
-4% -$1.08M 0.1% 198
2023
Q3
$27.3M Sell
394,145
-53,072
-12% -$3.68M 0.13% 156
2023
Q2
$42.2M Buy
447,217
+259,097
+138% +$24.4M 0.16% 130
2023
Q1
$15.6M Buy
+188,120
New +$15.6M 0.04% 283
2022
Q3
Sell
-35,604
Closed -$3.39M 1199
2022
Q2
$3.39M Buy
+35,604
New +$3.39M 0.04% 305
2021
Q4
Sell
-36,300
Closed -$4.11M 1030
2021
Q3
$4.11M Sell
36,300
-31
-0.1% -$3.51K 0.09% 181
2021
Q2
$3.76M Buy
36,331
+1,041
+3% +$108K 0.08% 183
2021
Q1
$2.95M Sell
35,290
-579
-2% -$48.4K 0.07% 203
2020
Q4
$3.27M Sell
35,869
-2,706
-7% -$247K 0.1% 156
2020
Q3
$3.08M Buy
38,575
+3,927
+11% +$313K 0.13% 130
2020
Q2
$2.4M Buy
34,648
+85
+0.2% +$5.88K 0.13% 122
2020
Q1
$2.17M Sell
34,563
-1,692
-5% -$106K 0.14% 128
2019
Q4
$2.82M Buy
36,255
+1,020
+3% +$79.3K 0.14% 123
2019
Q3
$2.58M Buy
35,235
+657
+2% +$48.2K 0.15% 136
2019
Q2
$2.13M Sell
34,578
-3,309
-9% -$204K 0.13% 147
2019
Q1
$2.42M Sell
37,887
-108
-0.3% -$6.89K 0.16% 146
2018
Q4
$1.94M Sell
37,995
-3,741
-9% -$191K 0.13% 160
2018
Q3
$2.42M Buy
41,736
+2,241
+6% +$130K 0.17% 141
2018
Q2
$1.92M Buy
39,495
+279
+0.7% +$13.5K 0.14% 157
2018
Q1
$1.82M Sell
39,216
-183
-0.5% -$8.51K 0.14% 160
2017
Q4
$1.48M Sell
39,399
-1,680
-4% -$63.1K 0.1% 188
2017
Q3
$1.5M Buy
+41,079
New +$1.5M 0.11% 189
2017
Q2
Sell
-39,168
Closed -$1.23M 373
2017
Q1
$1.23M Buy
+39,168
New +$1.23M 0.1% 166